Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT01035021
• Date of registration: 17/12/2009
• Primary sponsor: Seoul National University Bundang Hospital
• Public title: Neuromuscular Block in Laryngeal Mask Airway(LMA) Insertion
• Scientific title: Effect of Neuromuscular Blockade on the Insertion of ProSeal™ Laryngeal Mask Airway and Postoperative Pharyngolaryngeal Discomfort
• Date of first enrolment: June 2009
• Target sample size: 182
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT01035021
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention

Countries of recruitment

Korea, Republic of

Contacts

• Name: Hyoseok Na, Pf
• Affiliation: Seoul National University Bundang Hospital

Key inclusion & exclusion criteria

Inclusion Criteria:

- 18-70 year

- american society of anesthesiologist status 1-2

- elective general anesthesia

Exclusion Criteria:

- known or predicted difficult airway

- recent sore throat

- mouth opening less than 2.5 cm

- at risk of aspiration



Age minimum: 18 Years
Age maximum: 70 Years
Gender: Female

Health Condition(s) or Problem(s) studied

Breast Disease

General Anesthesia

Intervention(s)

Drug: use of rocuronium when the LMA is inserted

Primary Outcome(s)

success rate and insertion time [Time Frame: when laryngeal mask airway is inserted]

Secondary Outcome(s)

complication after the remove of LMA - bleeding, sore throat [Time Frame: 30 minutes and 6 hours after the LMA is removed]

Secondary ID(s)

LMA_M_relax

Source(s) of Monetary Support

Please refer to primary and secondary sponsors